These results are consistent with previous reports showing that CD36 mediates free radical production in many neuroinflammatory conditions including Alzheimer disease and cerebral ischemia [11], [33], [34], and support a key role of CD36 in prion diseases-associated oxidative stress by triggering iNOS up-regulation and NO production. Here, NOS2 is linked to early-onset autosomal dominant Alzheimer disease.